Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of Nicotine Delivery from E-Cigarettes
NCT04258852Withdrawn
- Sponsor
- Yale University
- Start
- Dec 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nicotine in Tobacco Use Disorder (TUD) (2 arms), sponsored by Yale University. Primary endpoint: Brain beta-2 nicotinic acetylcholine receptor occupancy at 210 minutes. Planned start Dec 2022; status: withdrawn.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04258852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04258852.